Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Part of paid clinical trials in Kansas City, Kansas.

Sponsor
University of Kansas Medical Center
Study ID
NCT03413982
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Registry — OTHER
    Patient registry

Study Details

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Key Dates

Start date
Nov 2, 2017
Status verified
Mar 2026
Primary completion
Jan 1, 2035
Completion
Jan 1, 2035

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: BC Patients
    Patients with bladder cancer. This registry involves no intervention. Blood, urine, and tissue samples will be collected to be used for research.

Primary Outcome Measure

Blood, urine and tissue characteristics of bladder cancer patients [ Time Frame: 24 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Kansas Medical CenterKansas CityKansas66160-

Find similar trials in Kansas City, KS

By condition
Bladder cancer
By specialty
OncologyUrology
By research site
University of Kansas Medical Center· Kansas City, KS

Related Studies